Recent Updates
Recently added Catalysts
SIGA Positive Sentiment

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

Key Takeaway: SIGA Technologies, Inc. will host a business update call on November 9, 2026, at 4:30 P.M. ET. CEO Diem Nguyen and CFO Daniel Luckshire will participate. The call will cover the company's third-quarter financial results and can be accessed via phone or webcast. A replay will be available for two weeks.

Market Sentiment Analysis

POSITIVE FACTORS

  • SIGA is hosting a business update call.
  • Management will discuss third-quarter financial results.
  • The company focuses on innovative medicines for infectious diseases.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+130%
120-day peak, hindsight
Typical move
11.1%
average across 2 past catalysts
Lead asset
Tecovirimat
Phase 3 · Smallpox

Full Press Release Details

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time.
Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers.
A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130564. The archived webcast will be available in the Investor Relations section of the Company's website.
About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world’s most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. For more information about SIGA, visit www.siga.com.

Contact: Suzanne Harnett sharnett@siga.com

Frequently Asked Questions

When is SIGA's business update call scheduled?

The call is scheduled for November 9, 2026, at 4:30 P.M. ET.

Who will participate in the SIGA call?

CEO Diem Nguyen and CFO Daniel Luckshire will participate.

How can I access the SIGA update call?

You can access it via phone or through the webcast on SIGA's website.

Will there be a replay of the SIGA call?

Yes, a replay will be available for two weeks after the call.

Last updated: Oct 29, 2026